Venus Medtech (Hangzhou) Inc. (2500.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 936.1M |
| Enterprise Value | 977.49M |
| P/E Ratio | -0.8 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 1.46 |
| Price/Book Ratio | 0.24 |
| Enterprise/Revenue | 1.91 |
| Enterprise/EBITDA | -1.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.82 |
| Operating Margin | -1.49 |
AD
Management Effectiveness
| Return On Assets | -0.21 |
| Return On Equity | -0.28 |
Income Statement
| Revenue | 306.79M |
| Revenue/Share | 0.58 |
| Gross Profit | 211.83M |
| EBITDA | -247.99M |
| Net Income | -407.69M |
| Diluted EPS | -0.93 |
Balance Sheet
| Total Cash | 88.2M |
| Total Cash/Share | 0.2 |
| Total Debt | 202.65M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 1.3 |
| Book Value Per Share | 3.48 |
Price History
| 52-Week Change | -59.84 |
| 52-Week High | 3.86 |
| 52-Week Low | 0.94 |
| Moving Average 50 Days | 1.1 |
| Moving Average 200 Days | 1.59 |
Statistics
| Average Volume | 603,102 |
| Shares Outstanding | 437.9M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
